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Introduction: Protein and electrolyte concentration of synovial ﬂuid (SF) varies with the type of under-
lying arthritis. These characteristics can be utilized by magnetic resonance technology to provide
a potentially signiﬁcant diagnostic modality through quantitative assessments of inherent water relax-
ation rates and their response to contrast agents.
Methods:We evaluated the effect of a classic “in vitro” contrast agent, the Mn ion, and a common “in vivo”
gadolinium based contrast agent, gadopentetate dimeglumine, on the water relaxation times of solutions
with biochemical compositions simulating different types of arthritis along with similar studies of SF
obtained from patients.
Results: The results demonstrate how protein and electrolyte concentrations play a signiﬁcant role in the
response of water relaxation to the Mn ion but much less so to chelated gadolinium contrast agents used
clinically.
Discussion: A major challenge remains to develop paramagnetic agents with less toxicity than the Mn ion
but with similar properties that can then serve as a tool to determine protein concentrations through
imaging and thereby assist in the diagnosis of inﬂammatory arthrides and evaluation of therapeutic
regimens.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Normal synovial ﬂuid (SF) is an ultraﬁltrate of plasma. Plasma
proteins are delivered to the articular tissues by the microcircula-
tion and removed by lymphatic drainage. Factors affecting the SF
protein concentration include not only the molecular radius of each
protein but also the abundance of synovial microvessels and
transsynovial kinetics. Net intraarticular synthesis or catabolism of
proteins also plays a role1. The varying types of arthritis’ differen-
tially affect these factors, such that by biochemical analysis, SF fromaedic Surgery and Radiology,
: Robert V. Mulkern, Depart-
SA.
.edu (R.V. Mulkern).
tant Professor, Orthopaedic
500, Karachi 74800, Pakistan.
s Research Society International. Ppatients with rheumatoid arthritis (RA) has a greater protein
concentration than that from normal subjects and patients with
Osteoarthritis (OA)2. Similarly, electrolyte compositions and
concentrations in SF also vary with disease state. These factors
inﬂuence the water longitudinal and transverse relaxation rates, R1
and R2 respectively, associated with SF signal intensities in
magnetic resonance imaging (MRI) and also play an important role
in how these relaxation times respond to MRI contrast agents. In
this work, the effect of a classic “in vitro” contrast agent, the Mn ion,
and a common “in vivo” gadolinium (Gd) based contrast agent
(Magnevist) on the water relaxations times of solutions with
biochemical compositions mimicking those in various types of SF
are examined along with similar studies of SFs extracted from
subjects. There have been previous contrast agent relaxation
studies in which the biochemical environment of speciﬁc tissues is
simulated including studies designed to examine the effects of Gd-
DTPA2 on articular cartilage relaxation times3 and the more
general case of macromolecular content on the efﬁcacy of waterublished by Elsevier Ltd. All rights reserved.
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effects of the native biochemical milieu within SF on the efﬁcacy of
clinical and research type contrast agents to alter relaxations times
has not been examined.
Materials and methods
Four separate experiments were performed in order to charac-
terize how protein concentration and composition, temperature
and electrolyte composition within SF type solutions and actual SF
samples inﬂuences the efﬁcacy of the Mn ion or a common Gd
contrast agent in altering water proton relaxation rates. The design
of each experiment is described below followed by a description of
the MR acquisitions and data analyses common to all four
experiments.
Experiment 1
Effects of protein concentration on R1 and R2 relaxation rates in
the presence of the manganese ion were examined in the absence
and presence of normal SF electrolytes. Protein solutions consisting
of dissolved bovine serum albumen (BSA, SigmaeAldrich, St Louis,
MO) from 0.063 to 0.632 mM were prepared in stock solutions of
distilled water with added concentrations of either 0.3 or 0.5 mM
MnCl2. Identical solutions but with the added electrolytes sodium,
potassium, chloride, bicarbonate, lactate and calcium electrolytes at
concentrations mimicking normal SF, as shown in the second
column of Table I, were also prepared.
Experiment 2
Effects of temperature on R1 and R2 relaxation rates and their
sensitivity to the manganese ion in solutions mimicking normal (N)
and RA SFs were examined. Solutions with concentrations of
0.316 mM and 0.630 mM BSAwere used to represent the N and RA
SFs, respectively, and titrated with MnCl2 from concentrations of
0.0 to 0.5 mM. R1 and R2 measurements on these solutions were
performed at room temperature (w 22C) and at approximately
37C by heating the solutions in a 37C water bath and scanning
them within a Styrofoam container to retain heat during the
imaging experiments. Temperature drops during scanning were
estimated to be less than 2C.
Experiment 3
Effects of both Mn ions and the common gadolinium (Gd)
contrast agent (Magnevist@, active ingredient gadopentatate
dimeglumine, Bayer HealthCare Pharmaceuticals, Inc. Wayne, NJ)
on R1 and R2 relaxation rates in simulated synovial solutions
mimicking normal (N) and RA chemical compositions wereTable I
Simulated SF constituents2
SF constituents Simulated normal
SF concentration
Simulated RA
SF concentration
Hyaluronic acid 0.32 gm/dl 0.115 gm/dl
BSA 1.176 gm/dl 1.76 gm/dl
a and b globulins 0.55 gm/dl 1.39 gm/dl
g globulins 0.38 gm/dl 1.05 gm/dl
Naþ1 133.79 mmol/l 132.26 mmol/l
Kþ1 3.5 mmol/l 3.5 mmol/l
Cl1 106 mmol/l 106 mmol/l
HCO31 23 mmol/l 23 mmol/l
Lactate 1.6 mmol/l 5.7 mmol/l
Caþ2 2.1 mmol/l 2.1 mmol/lexamined. For this purpose, solutions were prepared according to
the compositions provided in Table I and included not only dis-
solved BSA but also a and b globulins Cohn Fraction IV-4, human,
and g globulins Cohn Fraction II, III, human, in addition to hyalur-
onic acid sodium salt, sodium chloride, potassium chloride, sodium
bicarbonate, lactic acid sodium salt and calcium chloride dehydrate.
These solutions were prepared in two sets. To one set, MnCl2 was
added at increasing doses to achieve a ﬁnal dilution from 0.0 to
0.5 mM. To the second set, the Gd contrast agent was added in
gradually increasing amounts to achieve ﬁnal dilutions from 0.0 to
3.0 mM Gd. Control solutions with only hyaluronic acid and elec-
trolytes at normal and RA levels were also prepared and titrated
similarly with MnCl2 and Gd. The normal and RA control solutions,
without the proteins, are referred to as NHE and RAHE, respectively,
and normal and RA solutions with the proteins are labelled NPHE
and RAPHE, respectively.Experiment 4
SF was obtained from four patients who had been previously
diagnosed with RA, Pigmented Villonodular Synovitis (PVNS),
Psoriatic Arthritis (PSORI) and OA. These ﬂuid specimens had been
previously obtained after appropriate informed consent was
obtained and were stored at 20C prior to evaluation. Relaxation
rates as functions of MnCl2 and Gd-DTPA concentration were
measured in all four samples except for the OA specimen sample for
which only MnCl2 measurements were made due to the limited
quantity of ﬂuid available for that study. The absolute protein
concentrations of the four SFs were provided in gm/dl by the
clinical laboratory at the Brigham and Women’s hospital using
standard assay methods.
Common to all four experiments were the relaxation rate
measurements of the various solutions. For these measurements,
1 ml samples of speciﬁcally prepared ﬂuids in polypropylene test
tubes were imaged using a 1.5 T imager (Signa; GE Medical
Systems, Milwaukee, WI) with a quadrature head coil. A singleFig. 1. Typical image (TR/TE¼ 1200/ms, three echo FSE sequence) of nine vials doped
with varying levels of Gd contrast agent (0e4 mm Gd) from which signal intensity
measurements are made from individual ROI’s like that shown for the central vial, top
row, where A¼ area of ROI, P¼ position of the coronal slice from isocenter, M¼mean
and SD¼ standard deviation of the signal intensity from the pixels within the ROI.
Signal intensities extracted from the vials as a function of TR and TE are used to
calculate the T1 and T2 values for each sample, as described in the text.
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Fig. 2. Top: longitudinal relaxation rates (R1) of water as a function of mM BSA
concentration in solutions doped with 0.3 or 0.5 mM MnCl2 and with (*) and without
the added electrolytes common to normal SF (Table I, second column). Solid lines
through the data are sigmoid ﬁts based on the one site binding equation (see text).
Bottom: transverse relaxation rates (R2) of water as a function of mM BSA concen-
tration in solutions doped with 0.3 or 0.5 mM MnCl2 and with (*) and without the
added electrolytes common to normal SF (Table I, second column). Solid lines through
the data are sigmoid ﬁts based on the one site binding equation (see text).
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selected for relaxation studies (Fig. 1). R1 measurements were
performed from a series of three echo fast spin echo (FSE)
sequences with an effective echo time (TE) of 12 ms and with
repetition time (TR) values ranging from 50 ms to 6000 ms. R2
measurements were performed with a 64 echo Carr-Purcell-Mei-
boom-Gill (CPMG) sequence with a 6000 ms TR and a 15 ms echo
spacing5. A 256 256 image matrix and 5 mm slice thicknesses
were employed with 16 kHz receiver bandwidths and one signal
average per phase encode. Signal intensities from regions-of-
interest within each vial consisting of approximately 0.15 ml of
material were extracted as functions of TR and TE for the R1 and R2
measurements, respectively. Figure 1 shows a typical image and
region-of-interest (ROI) measurement from which relaxation data
were obtained. Total acquisition times were approximately 1 h. The
relaxation data was analyzed with a Sparc workstation (SUN
Microsystems, Mountainview, CA) using the software program
Analyze by Mayo Clinic and the R1 and R2 values calculated
assuming standard monoexponential relaxation functions5.
For the Mn and Gd titration experiments, linear regression
analyses were performed of the R1 and R2 vs Mn or Gd mM
concentration plots in order to obtain the slopes, r1 and r2
respectively where lower case r1 and r2 are used to refer to the
relaxivities, in units of (s mM)1 for the longitudinal and transverse
relaxation rates R1 and R2, respectively.
For the BSA titration experiments (experiment 1), R1 and R2 vs
mM BSA concentration were ﬁt to a generic two free parameter
sigmoid function of the form
R1 ¼ R1max½mM BSA=fKd1 þ ½mM BSAg
with a similar equation for R2 where R1max and R2max are the
maximum “saturation” relaxation rates (at inﬁnite BSA concentra-
tion) and Kd1 and Kd2 are the concentrations of BSA (in mM) for
which the R1 or R2 relaxation rates, respectively, achieve half their
maximal values. The sigmoid ﬁts and linear regression analyses
were performed using GraphPad Prism software (GraphPad
Software, Inc. San Diego, CA).Table II
Parameters for the sigmoid ﬁts shown in Fig. 1(a and b) yielding maximal relaxation
rate values and concentrations of BSA for which the R1 and R2 relaxation rates
achieve half their maxima. Columns labelled with *’s indicate the presence of
electrolytes shown in column 2 of Table I
0.3 mM Mn 0.3 mM Mn* 0.5 mM Mn 0.5 mM Mn*
R1max (s)1 21.08 27.26 32.14 47.44
Kd1 (mM BSA) 0.18 0.14 0.21 0.26
R2max (s)1 44.47 60.98 87.83 129.7
Kd2 (mM BSA) 0.09 0.16 0.15 0.33Results
Figure 2 shows plots of R1 and R2 values as a function of BSA
concentration for solutions with 0.3 mM and 0.5 mM MnCl2 as
prepared with (*’s) or without the electrolytes present in typical
SFs (see second column of Table I). The curves show deﬁnitive
saturation behaviour and are reasonably well-characterized with
the best ﬁt sigmoid functions shown as solid lines through the data.
Sigmoid parameters for each of the eight ﬁts are provided in
Table II. Goodness of ﬁt parameters (r2 values) were all above 0.93
with the exception of the R2 0.5 Mn data with an r2 value of 0.83,
attributed to the difﬁculty in making accurate R2 measurements at
the higher end range (>50 s1) with the methods employed. A
cursory glance at Table II reveals that the presence of electrolytes
increases the maximal relaxation rates for both R1 and R2 data at
both the 0.3 and 0.5 mM Mn levels by approximately 30e50%.
Figure 3 shows plots of R1 and R2 relaxation rates vs MnCl2
concentration for the simulated normal (N) and RA solutions with
BSA concentrations of 0.316 and 0.630 mM, respectively at room
temperature (22C) and close to body temperature (37C). Table III
provides the relaxivities as found from the slopes of the linear
regressions shown as solid lines in the Figure. Correlation coefﬁ-
cients for the ﬁts were 0.98 or above. In general the higher
temperature resulted in attenuated effects of the Mn ion effect on
relaxation as observed by the smaller relaxivities, particularly for
transverse relaxation.The relaxivities, calculated from slopes of the solid lines though
the data shown in Figs. 4 and 5 for Mn and Gd contrast doping, for
the four solutions with SF electrolyte and hyaluronic acid concen-
trations as prepared without and with normal and RA levels of SF
protein compositions and concentrations (see Table I) are provided
in Table IV. Correlation coefﬁcients for the linear regression anal-
yses were >0.95. For the Mn ion a large difference between r1 and
r2 relaxivities is apparent but, in the absence of protein, differences
between normal and RA electrolyte and hyaluronic acid concen-
trations are small. In contrast, the presence of different levels of
protein for these two conditions (lower plot of Fig. 4) causes
considerable dispersion in the relaxation vs Mn curves and very
different relaxivities (Table IV, NPHE and RAPHE Mn results). In the
case of the Gd contrast agent, not only are there much smaller
relaxivities but also there are only minor differences (less than 20%)
between r1 and r2 relaxivities that are effectively unassociated
with protein and/or electrolyte composition.
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Fig. 3. Top: longitudinal relaxation rates (R1) of water as a function of mM MnCl2 in
solutions with normal (N) and RA levels of protein, mimicked with BSA at 0.316 and
0.630 mM respectively, as measured at 37C and 22C. Bottom: transverse relaxation
rates (R2) of water as a function of mM MnCl2 in solutions with normal (N) and RA
levels of protein, mimicked with BSA at 0.316 and 0.630 mM respectively, as measured
at 37C and 22C.
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Fig. 4. Top: R1 and R2 values vs Mn concentration for solutions with N and RA
concentrations of electrolytes and hyaluronic acid but no proteins. Bottom: R1 and R2
values vs Mn concentrations for solutions with N and RA concentrations of electrolytes,
hyaluronic acid and proteins.
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tration, respectively, for the SFs extracted from the subjects. Table V
provides the relaxivities calculated from this data with the linear
regression analyses shown as solid lines in the plots with correla-
tion coefﬁcients of 0.97 or above. As with the NPHE and RAPHE
solutions, Mn relaxivities were much higher and more dispersed
than the Gd relaxivities. The protein concentrations as obtained
from clinical laboratory tests of the four samples are provided in
Table VI.
Discussion
As MR technology continues to improve, quantitative assess-
ments of inherent water relaxation rates and their response to
a wide variety of contrast agents becomes a clinically accessible
reality with signiﬁcant diagnostic potential. For example, most
manufacturers now offer pulse sequence(s)/protocols along with
associated image processing software to generate R1, R2 and R2*
“maps” of anatomy of interest in the standard slice-by-slice format
for interpretation or region-of-interest measurement. Thus, an
understanding and appreciation of the many factors that canTable III
Temperature dependence of the R1 and R2 relaxivities, r1 and r2, from Mn ion
relaxation effects at 22C and 37C
0.316 mM BSA (N) 0.630 mM BSA (RA)
r1 (22C) (mM s)1 25.68 37.44
r1 (37C) (mM s)1 25.44 32.66
r2 (22C) (mM s)1 81.23 104.2
r2 (37C) (mM s)1 57.85 66.49
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Fig. 5. Top: R1 and R2 values vs Gd concentration for solutions with N and RA
concentrations of electrolytes and hyaluronic acid but no proteins. Bottom: R1 and R2
values vs Gd concentrations for solutions with N and RA concentrations of electrolytes,
hyaluronic acid and proteins.
Table IV
R1 and R2 relaxivities r1 and r2 for bothMn ion and Gd contrast agent solutions with
normal and RA concentrations of electrolytes and hyaluronic acid (NHE and RAHE)
and for the same solutions but with added proteins (BSA and human globulins) at
levels mimicking normal and RA concentrations of protein, labelled NPHE and
RAPHE
NHE RAHE NPHE RAPHE
r1 (mMMn s)1 6.61 7.45 34.48 53.18
r2 (mMMn s)1 34.63 38.32 82.62 130.9
r1 (mMGd s)1 5.63 5.27 6.16 5.91
r2 (mMGd s)1 4.99 4.56 5.38 5.40
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Fig. 7. R1 vs Gd concentration for the four SFs samples extracted from subjects with
S. Noordin et al. / Osteoarthritis and Cartilage 18 (2010) 964e970968inﬂuence relaxation times and their response to contrast agents in
the clinically relevant area of SF assessment is of interest and hel-
ped motivate this work. Though the protein and electrolyte content
of SF varies with disease, the changes in thesemoieties with disease
state are expected to have only small effects on the generally small
water relaxation rates (long relaxation times) associated with SF,
making exogenous contrast agent effects on SF relaxation rates
with disease state of signiﬁcant clinical interest. It should be noted
that due to the very long relaxation times of SF, relatively small
concentrations of contrast agent can make a big difference in signal
intensities observed in, for example, T1-weighted images, which is
why direct injection of Gd based contrast agents is possible and
indeed performed clinically7. If the relaxivity of the contrast agent
is furthermore sensitive to protein content and concentration, the
relatively large changes observed with only small contrast agent
concentrations may prove diagnostic.
The two contrast agents selected for our study represent in
some sense two extremes of potential contrast agents currentlyR1 MnCl
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Fig. 6. Top: R1 vs Mn concentration for the four SFs samples extracted from subjects
with PVNS, PSORI, RA and OA. Bottom: R2 vs Mn for the four SFs samples extracted
from subjects with PVNS, PSORI, RA and OA.
PVNS, PSORI, and RA. Bottom: R2 vs Gd for the four SFs samples extracted from
subjects with PVNS, PSORI, and RA.available with regard to their local interactions in the micro-envi-
ronment of SF with the Mn ion being quite interactive and the Gd
contrast agent being much less so. Previous workwith the standard
Gd contrast agents in SF include dynamic MR imaging of the uptake
and washout of the agent, the so-called delayed gadolinium
enhancedMR imaging of cartilage (dGEMRIC) technique3,6 with the
potential to assess glycosaminoglycan distributions in cartilage.
Also, an interesting study by Ganguly et al. examined the competing
effects on water relaxation caused by iodinated X-ray contrast
agents used in some MR arthrography procedures for needle
placement with subsequent Gd contrast agent for MR acquisition7.
To our knowledge, however, the effects of background chemical
constituents within normal and pathological SF on the relaxivities
of commercial Gd contrast agents or the Mn ion have not been
performed.
The positively charged Mn ion is known to not only directly
affect water relaxation rates but also to bind to proteins such as
albumen and globulins8e13. The binding of the Mn ion to proteins
reduces the overall tumbling rate of the paramagnetic source and as
such can signiﬁcantly enhance the ability of the Mn ion to causeTable V
R1 and R2 relaxivities r1 and r2 for both Mn ion and Gd contrast agent solutions for
SFs extracted from four different patients having been diagnosed with RA, PVNS,
PSORI and OA
PVNS PSORI RA OA
r1 (mMMn s)1 56.93 38.76 42.04 34.08
r2 (mMMn s)1 124.1 79.23 82.59 75.56
r1 (mMGd s)1 4.29 3.84 3.68 NA
r2 (mMGd s)1 3.86 3.45 3.33 NA
Table VI
Protein concentrations of the four SFs extracted from patients as reported from
clinical laboratory testing
Disease Protein concentration (gm/dl)
RA 3.9
PVNS 4.0
PSORI 4.8
OA 2.4
S. Noordin et al. / Osteoarthritis and Cartilage 18 (2010) 964e970 969water relaxation. On the other hand, some “tight” binding sites on
proteins may restrict access of the Mn ion to water and so effec-
tively reduce the ability of the Mn ion to cause water relaxation. In
either case, the number and nature of the binding sites are expected
to depend sensitively on the actual proteins present as well as their
conformations, the latter being affected by the presence of elec-
trolytes which can 1) compete for binding sites and 2) alter the
electrostatic interactions, e.g., van der Waals, hydrogen bonding,
etc, which determine the protein conformations. As the protein and
electrolyte concentrations of SF vary widely among different
diseased states, it may be anticipated that the relaxivities induced
by Mn ions will also vary widely and so be sensitive, and possibly
diagnostic, to conditions affecting SF chemical compositions. The0 0.1 0.2 0.3 0.4 0.5 0.6 0.7
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Fig. 8. Top: the r1 relaxivities from 0.3 to 0.5 mM Mn concentrations as a function of
BSA concentration as calculated from the sigmoid parameters in Table II when elec-
trolytes are present (þ’s) and when no electrolytes are present (o’s). Bottom: the r2
relaxivities from 0.3 to 0.5 mM Mn concentrations as a function of BSA concentration
as calculated from the sigmoid parameters in Table II when electrolytes are present
(þ’s) and when no electrolytes are present (o’s).standard Gd contrast agents, on the other hand, have been engi-
neered to largely avoid molecular interactions with proteins and
other macromolecules, reducing their physiological impact and, of
course, toxicity. The particular agent we used, Magnevist, is nega-
tively charged at physiologic pH and has been shown to have some
interactions with positively charged moieties such as the choline
containing compounds detected with proton magnetic resonance
spectroscopic (MRS)methods14. In all, however, the chelation of the
Gd ion in this agent and other common neutral or negatively
charged Gd chelates used in clinical practice14 largely result in
similar water proton relaxivities with much less dramatic sensi-
tivities to the chemical compositions of real or simulated SF
solutions.
The results presented above demonstrate that the Mn ion
indeed produces water relaxivities much more sensitive to the
chemical composition of simulated and actual SF solutions than
a standard Gd contrast agent. The dependence of electrolytes on the
relaxivities associated with the Mn ion may be examined in greater
detail using the binding curve parameters estimated from the data
in Fig. 2 and provided in Table II. Namely, the sigmoid ﬁtting
parameters in Table II allow us to predict two point (0.3 mM Mn
and 0.5 mM Mn) relaxivity estimates for both R1 and R2 as func-
tions of BSA concentration. The predicted plots of relaxivity vs BSA
concentration is provided in Fig. 8 for the data with electrolytes
present and electrolytes absent. Note that at low concentrations of
BSA, the relaxivities are larger in the absence of electrolytes,
probably due to a lack of competition, particularly with calcium, for
binding sites in the these solutions as compared with those con-
taining electrolytes. As BSA concentration is increased, however,
relaxivities in the solutions with electrolytes become larger than
those without, possibly due to differences in conformation of the
protein providing increased binding sites for the Mn ion. Increasing
the temperature of the solutions resulted in reduced relaxivities,
again attributable to decreased overall binding at the higher
temperatures (Table III). Furthermore, the experiments with just
electrolytes and HA as compared with similar solutions but con-
taining proteins (Table IV) conﬁrms the hypothesis that proteins
play the signiﬁcant role in how well Mn enhances water proton
relaxivities whose sensitivity to the Gd contrast agent is largely
unaffected by either electrolytes or proteins (Table IV).
Though the details of the actual binding processes occurring in
the Mn/protein solutions are considerably more complicated than
our data and analyses can reveal, the basic observation that the
degree of relaxation of water imparted by a contrast agent like
the Mn ion is exquisitely sensitive to the chemical composition of
the SF solutions may ultimately prove useful in the setting of
disease assessment. This is further suggested from the experiments
with actual SFs from subjects (Tables V and VI). Speciﬁcally, the Gd
contrast agent produced similar relaxivities under all conditions
while the Mn relaxivities varied signiﬁcantly between samples.
Intriguingly, the PVNS sample which did not have the highest
protein content according to laboratory results (Table VI) did have
the highest relaxivities, indicating secondary effects of electrolytes
of different types of proteins with the samples not assessed
clinically.
The impact of the Mn ion as a contrast agent can be found in the
earliest stages of MRI10. Problems with toxicity slowed the devel-
opment of the Mn ion as a useful MRI contrast agent though there
has been a recent resurgence of interest in its use as an MRI
contrast agent11. The search for strategies to get more detailed
physiological, biochemical and molecular biological information
from MRI certainly points towards agents like the Mn ion whose
effect on water relaxivities depends sensitively upon the chemical
milieu which in SF is directly associated with severity and type of
disease. A major challenge remains to develop paramagnetic
S. Noordin et al. / Osteoarthritis and Cartilage 18 (2010) 964e970970agents with less toxicity than the Mn ion but with similar prop-
erties that can then serve as a tool to determine protein concen-
trations and/or compositions through imaging and thereby assist
in the diagnosis of inﬂammatory arthrides and assessment of
therapeutic regimens.
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